TENAX THERAPEUTICS, INC. Business Combination, Consideration Transferred, Equity Interests Issued and Issuable
TENAX THERAPEUTICS, INC. (TENX) reported Business Combination, Consideration Transferred, Equity Interests Issued and Issuable of $3.37 million for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-31.
Discontinued › Notes › Business Combinations › Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation › Business Combination, Consideration Transferred
us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable · last filed 2023-03-31
- TENAX THERAPEUTICS, INC. business combination, consideration transferred, equity interests issued and issuable for the quarter ending 2022-12-31 was $0.00.
- TENAX THERAPEUTICS, INC. business combination, consideration transferred, equity interests issued and issuable for the quarter ending 2022-09-30 was $0.00.
- TENAX THERAPEUTICS, INC. business combination, consideration transferred, equity interests issued and issuable for the quarter ending 2022-06-30 was $0.00.
- TENAX THERAPEUTICS, INC. business combination, consideration transferred, equity interests issued and issuable for the quarter ending 2022-03-31 was $3.37M, a 0.00% change year-over-year.
- TENAX THERAPEUTICS, INC. business combination, consideration transferred, equity interests issued and issuable for fiscal 2022 was $3.37M, a 0.00% change from fiscal 2021.
- TENAX THERAPEUTICS, INC. business combination, consideration transferred, equity interests issued and issuable for fiscal 2021 was $3.37M.
| Period end | Business Combination, Consideration Transferred, Equity Interests Issued and Issuable 3 month | Business Combination, Consideration Transferred, Equity Interests Issued and Issuable 6 month | Business Combination, Consideration Transferred, Equity Interests Issued and Issuable 9 month | Business Combination, Consideration Transferred, Equity Interests Issued and Issuable 12 month |
|---|---|---|---|---|
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $0.00 derived: sum of 2 quarters · filed 2023-03-31 | $0.00 derived: sum of 3 quarters · filed 2023-03-31 | $3.37M 10-K · filed 2023-03-31 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $0.00 derived: sum of 2 quarters · filed 2022-11-10 | $3.37M 10-Q · filed 2022-11-10 | $3.37M derived: sum of 4 quarters · filed 2022-11-10 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $3.37M 10-Q · filed 2022-08-11 | $3.37M derived: sum of 3 quarters · filed 2022-08-11 | $3.37M derived: sum of 4 quarters · filed 2022-08-11 |
| 2022-03-31 | $3.37M 10-Q · filed 2022-05-16 | $3.37M derived: sum of 2 quarters · filed 2022-05-16 | $3.37M derived: sum of 3 quarters · filed 2022-05-16 | $3.37M derived: sum of 4 quarters · filed 2022-05-16 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | $0.00 derived: sum of 2 quarters · filed 2022-03-29 | $0.00 derived: sum of 3 quarters · filed 2022-03-29 | $3.37M 10-K · filed 2022-03-29 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $0.00 derived: sum of 2 quarters · filed 2021-11-15 | $3.37M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | $3.37M 10-Q · filed 2021-08-16 | ||
| 2021-03-31 | $3.37M 10-Q · filed 2021-05-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |